Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
Following a peak at week 51/2022, influenza activity had been decreasing across the Region until week 4/2023, before rising again to fluctuate around 25% positivity between weeks 6 and 11/2023 and decreasing below 10% positivity in week 16/2023.
Following a peak at week 51/2022, influenza activity had been decreasing across the Region until week 4/2023 when it reached 21% positivity, before rising again to fluctuate around 25% positivity between weeks 6 and 11/2023 and is coming to an end with positivity falling below the 10% seasonal threshold in week 16/2023 (9%).